Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Hi momentum, this was more than what I expected today though I'm very happy having got into these at a very good price. Look at the snippet I have posted from the Home Page and gives some indication as to why the huge buying occured today.

Signs were there last week that the price was going to start rising :

1. EVO upgrade (Buy note) came out on Wednesday
2. The above was mentioned in the Daily Mail Newspaper on Saturday
3. The sellers had been cleared by end of last week
4. TA indicators were improving (especially the above candlestick chart where I specifically mentioned how a blue candlestick was formed for friday when there shouldn't have been one, and the bullish sticks for the previous 2 days)

Hi sue, cant see a lot of resistance up to 8p, where it will be flirting with the 200 day. I would expect a slight pull back from here ( 10-15%)

Next resistance point is exactly at 8.10 pence.

Hi Momentum, I bought more today at 6.55 pence (about 64,000 odd shares) adds to my holding of 100,000 shares at 4.95 pence which was purchased last week. I think these could do very well in the next month or so.

Check out their website and look at the customer list and the geography....massive potential for ETQ if this comes off..and not just in the USA.....

http://www.nqinc.com/a.html

Buys still slowly trickling in which shows how ETQ is on many radars albeit not at yesterday's ferocity.

Buys come to about 1.0 million shares for today and sells are about 470,000.

Level 2 stable at 1 v 1.

Buyers took the upper hand again following on from yesterday, very encouraging that the price held onto its gains (besides the offer price moving from 7.00 pence to 6.75 pence, ie. the spread became better) as well from yesterday.
250,000 delayed buy at 6.50 pence came through at 5.22pm from an hour ago.

Figures :

Buys = 1,554,825
Sells = 597,047.

Best - Charts at close :

2 Buy Signals
0 Sell Signals

13 Bullish Indicators
3 Bearish Indicators.



MACD (Moving Average Convergence/Divergence) is poised to the crossover soon and go bullish (see above MACD indicator).

Interesting project being conducted in the US :

CU-Boulder Professor To Study Controls For Hospital-Acquired Infections
Feb. 2, 2004

A new study that aims to significantly reduce the incidence of hospital-acquired infection by providing clear data on the effectiveness of ultraviolet germicidal irradiation (UVGI) is getting under way at the University of Colorado at Boulder.

The overall goal of the study, which is being funded by the N.G. Gilbert Foundation, is to quantify the effectiveness of ultraviolet germicidal irradiation, or UVGI, in controlling hospital-acquired infections from opportunistic airborne bacteria and fungi.

The research is being led by CU-Boulder engineering Professor Shelly L. Miller. Miller is an expert on indoor air quality, assessing exposures to infectious diseases and developing and evaluating control measures.

The rate of hospital-acquired infection has remained stable over the last 25 years at six per 100 hospital admissions, although the rate per 1,000 patient days has increased 36 percent because of shorter inpatient stays. In 1995, it was estimated that hospital-acquired infections resulted in medical costs of $4.5 billion and contributed to more than 88,000 deaths.

Miller has conducted previous studies on UVGI controls for reducing exposure to infectious diseases for the National Centers for Disease Control and Prevention and the National Science Foundation. The studies have looked at a variety of factors that can influence the effectiveness of UVGI but have shown that under the proper conditions, UVGI has significant potential to inactivate airborne bacteria and prevent infection in hospitals.

Two UVGI systems will be investigated in the new study: one is an in-room system that achieves irradiation of upper-room air through wall- and ceiling-mounted UV lamps; the second is an in-duct system installed in HVAC equipment.

The research will be conducted in two phases, the first of which will take place over a six-month period in a controlled laboratory setting at CU-Boulder's College of Engineering and Applied Science. Phase II will then involve controlled studies at the University of California-Los Angeles Medical Center.

The current design of Phase II includes testing first in unoccupied patient rooms retrofitted with proven UVGI systems, followed by detailed clinical studies of the effectiveness of UVGI against hospital-acquired infections.

The Gilbert Foundation hopes the study findings will be the catalyst for medical facilities to begin using UVGI on a comprehensive basis to significantly reduce hospital-acquired infections.


Contact: Shelly L. Miller, (303) 492-0587
Carol Rowe, (303) 492-7426

http://www.colorado.edu/news/releases/2004/30.html

Investtech Analysis updates after today's close : TA has improved greatly this week from the improved TA of last week.

Weak Positive Candidate (Short term) - Aug 3, 2004
Has broken the ceiling of the falling trend, which indicates a slower initial falling rate. The stock has support at p 5.10 and resistance at p 8.10. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Neutral (Medium term) - Aug 3, 2004
Shows a weak development within a falling trend channel. A further negative development is indicated, and there is resistance against the ceiling of the trend channel. The moving average indicator has, however, given a positive signal. In isolation this signals a continued rise, but the slowness of the indicator often means that one has lost much of the upside. The stock has support at p 3.50 and resistance at p 11.20. The RSI curve shows a rising trend, which is an early signal for a possible trend break up. The stock is overall assessed as technically neutral for the medium long term.

Positive Candidate (Long term) - Aug 3, 2004
ENERGY TECH. ORD 1P does not show any clear trend. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which strengthens the stock. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically positive for the long term.

SueHelen

How long is long term. 1 week, 1 month, 1 year or several years.
I know this is Mystic Meg stuff but any pointers would be great.

You certainly do your home work. You've got to be in the pro league.

Regards
Mickeyskint

SH get your people into FAR and SPD NOW

Hi Mickey, long term for me is about 6 months, medium term for myself is about 3 months & short term again for myself is about 1 month.

Press mention : was in today's Daily Mail Newspaper, page 58.

Heavy buying in response to an Evolution recommendation lifted Energy Technique 1 1/4 p to 6 5/8 p.

SueHelen,

I read your posts and find them very informative. Can you tell me what TA stands for in your post of 175.

Hi Safety, TA is an abbreviation I use for Technical Analysis.

Level 2 at 1 v 3, MMs are shaking the price today to get stock back, barely any sells.
The market makers need to balance their books, they have sold 6-7 million shares this week and have got back about 1.75 million shares this week. That's all there is to the small drop today. Buys still trickling in.
Evident with the way buys still outweigh sells today :

Buys = 211,489
Sells = 182,741.

Treeshake is so evident, there are just no sellers about. Need to balance their books ???

The same actions occured last week and it was so evident. These kind of actions normally happens before good news is about to come...same occurence last week before the EVO buy note came.

Important when these kind of actions occur it is a good ideas to see what they do with the offer price, as any would be buyer need to look at that, with the bid price they'll keep moving it around to get stock back. Keep an eye on the offer price, see how low that goes if it does do so.

I think the price will consolidate at 6.00 pence now this week just like the price consolidated and built support at 5.00 pence last week. Then the price may follow onto 7.00-7.50 pence next week.

High volume days in rising prices and low volume days in falling prices strengthens the stock. This occurence has been happening to ETQ since the product sale announcement in the first week of July.

I have bought now. All short term indicators are screaming buy on this short term chart and the necessary retracement has happened. Buyer beware and look at my later posting re long term trend, which is down. This buy refers only to the short term trend

Hi Snip, re : my posts last week, I had a feeling that it was going to happen as my TA was giving me the indication of a nice uptrend about to happen. Anyway I'm in at 4.95 pence from last week and bought another four thousand pounds worth yesterday at 6.55 pence.

The Market Makers got it so wrong with their attempted treeshake today, they could not get much stock back.

At close :

BUYS = 348,285
SELLS = 344,279
????? = 12,741.

25 Buy Trades
11 Sell Trades
1 ???? Trade.

Buyers continued to accumalate stock for the third consecutive trading day.

SueHelen

You seem keen on this stock and I was tempted to get on board. But before doing so decided to do some research.

This company has a risk grade of 713 bearing in mind the FT100 is 100. This is higher than DES which is frontier stuff it's self. Also its revenue for end of march 04 was 10.819 with a pretax loss of -1.472, net income -1.472 and total share capital/reserves of -0.211. The last div paid was 1998.

This one to me seems a real risk. Why are you so positive about it with a balance sheet like this.

Off to light the bbq and have a couple of g&t's so I won't be able to pick up your reply untill tomorrow.

Regards
mickeyskint

mickey I agree with you. I got over 4000 shares for 300. That is a small fraction of my spend on a `reliable` stock. Chartwise risk/reward is pretty good though with a SL at 4.60 and a potential rise to 15. However I shall be watching carefully.

Have a look at the HSD thread to see how I handle a risky stock

Hi Mickey,

There wasn't anything surprising or untoward in the results, the market was expecting a loss of around 1 million pounds.

From the Product Sale announcement in the first week of July :

Product sale

The Company is pleased to announce the sale of its first Nightingale air filtration system - developed to kill the MRSA hospital superbug, TB, and other dangerous germs - into the US healthcare system. The first unit will be sold to the Northwest Hospital Center in Randallstown, Maryland.

Energy Technique Managing Director Leigh Stimpson said: Following the careful development and pre-marketing work we have put into Nightingale, this sale is ahead of our expectation on timing and is great news for the Company.

We are confident further sales will follow in due course both within the UK and US in line with our business plan and validates the Companys extensive development of the product. Further to this we believe the sale can only strengthen our case for this product to be used within the NHS.

Nightingale uses ultraviolet radiation combined with sophisticated air flow systems to attack the DNA of killer germs such as the MRSA hospital superbug, anthrax and TB.

Financial Times on 10 July 2004 :

Mentioned ENERGY TECHNIQUE as one of the SHINERS of the previous week stating that with the USA deal the UK deals with the NHS should follow due to this breakthrough!

Reply from the Department of Health :

Thank you for your e-mail of 12 July 2004.

The majority of bacteria transmitted between patients are transferred on
the hands of attendants, hence the continued emphasis placed on hand
decontamination before patient contact. The problem of airborne
transmission is associated with specific problems such as the potential for
fungal infection in cancer patients and the spread of respiratory viruses.

The Government is always interested to hear of new products, however you
will understand that we cannot endorse any particular one. Introduction of
a new product would need careful consideration by Trusts to establish the
evidence that it prevents infection and has no adverse effects on patients.
It is to help the NHS make such assessments that we are developing a rapid
review process to assess new procedures and products for which claims of
effectiveness are made for their ability to prevent or control healthcare
associated infections (HCAIs). We will contact Energy Technique when the
review process has been etstablished.

This is part of our new approach to tackling healthcare associated
infections, "Winning Ways - Working together to reduce Healthcare
Associated Infection in England", published on 5th December. This is
available at http://www.dh.gov.uk/assetRoot/04/06/46/89/04064689.pdf. This
is part of our drive to put quality of care and patient safety at the heart
of NHS practice and we are confident that implementation of "Winning Ways"
will reduce infection rates.

Yours sincerely

Shares Magazine on 15 July 2004 :

With almost a 10% risk of infection for hospital in-patients from the MRSA superbug, TB, anthrax and other dangerous germs, the government has launched a campaign to cut the death toll.

One beneficiary should be Energy Technique (AIM:ETQ) whose shares have doubled to 8p since it announced the first US sale of its Nightingale air filtration system to the Northwest Hospital Center in Randallstown, Maryland. More US sales are expected to be announced shortly. The system, a free standing air conditioner the size of an American fridge and costing 5,000 uses ultrviolet radiation combined with sophisticated qir flow systems to attack the DNA of killer germs.

The lenghty trial of two units at Basingstoke Hospital comes to an end in Autumn. Energy Technique is hopeful this will finally kick start long-awaited sales to the NHS.

Meanwhile licensing and manufacturing deals have beed struck with major companies to gear up production assuming demand takes off. The company's own factory at Basingstoke can make only about 1,000 units a year.
Full results will be released shortly and will show a 1 Million-plus loss. The company is trading profitably and is well funded after a 3 Million placing at 4p a share in March

Shares Says: Air Filtration market offers huge potential

17 July 2004 :

Tipped by City Equities in their July newsletter !

Below is the copy of the BUY note from Evolution Beeson Gregory (EVO) which came out last week who upgraded ETQ from add to outright BUY :

Energy Technique (ETQ) Buy (from Add)
Mkt cap: 8m Net cash: 1m Recommendation change Price: 5p
Set to hot up
Over the last week the share price has fallen by nearly 40%. Our
fundamental view of the business remains in tact and we are raising our
recommendation to a BUY.
On 7th July Energy Technique announced it had sold its first Nightingale air
filtration system in the US. Investors responded positively and the share
price doubled. Whilst we remain confident the shares remained good value
in the long term, the shares looked unlikely to perform in the short term.
Therefore, on 21st July we reduced our recommendation to Add. Since then
the shares have fallen c 40% and we once again see some short term upside
in the share price. As a consequence we are raising our recommendation
back to a BUY.
We anticipate share price movements over the coming months are likely to
be stimulated by news flow from either the branded distribution operation
or the air treatment division. Preliminary results showed the branded
distribution operation is now established and poised to move into
profitability during the current financial year. We would expect the
company to update the market on its progress at the AGM stage. However,
the largest potential upside resides within the air treatment side of the
business. As experienced earlier this month, the market is likely to respond
favourably to any positive news flow from the division.
Following share price fall we are
raising recommendation to BUY
News flow will be key
ENERGY TECHNIQUE

Check out the improved website at :

http://www.energytechniqueplc.co.uk